Table 5 Univariate analysis of IMRT patients
From: Clinical evaluation of intensity-modulated radiotherapy for locally advanced pancreatic cancer
Factors | Number of patients | 1-year LRPFS (%) | p-value | 1-year OS (%) | p-value |
|---|---|---|---|---|---|
Age (years) | |||||
< 66 | 12 | 50 | 0.015 | 83.3 | 0.21 |
≥66 | 15 | 92.9 | 100 | ||
Gender | |||||
Male | 17 | 68.8 | 0.63 | 93.8 | 0.72 |
Female | 10 | 80 | 90 | ||
Tumor size | |||||
< 3 cm | 19 | 72.2 | 0.36 | 94.4 | 0.23 |
≥3 cm | 8 | 75 | 87.5 | ||
Radiation dose | |||||
< 45 Gy | 9 | 33.3 | 1.23E-07 | 88.9 | 0.000077 |
≥45 Gy | 18 | 94.1 | 94.1 | ||
PS | |||||
0 | 15 | 60 | 0.41 | 86.7 | 0.47 |
1 | 12 | 90.9 | 100 | ||
Pretreatment CA19–9 (U/ml) | |||||
< 300 | 17 | 87.5 | 0.032 | 100 | 0.037 |
≥300 | 10 | 50 | 80 | ||
Tumor location | |||||
Body/Tail | 11 | 54.5 | 0.25 | 81.8 | 0.12 |
Head/Neck | 16 | 86.7 | 100 |